Advancing personalized cancer medicine in lung cancer.
Abstract
Although improvements in genomic technologies during the past decade have greatly advanced our understanding of the genomic alterations that contribute to lung cancer, and the disease has (to a degree) become a paradigm for individualized cancer treatment in solid tumors, additional challenges must be addressed before the goal of personalized cancer therapy can become a reality for lung cancer patients.
我要评论
本期排行
- Tertium non datur? Legitimacy ...
- The Lower Anogenital Squamous ...
- Precision medicine for lung ca...
- Detection of silicone in lung ...
- The transformation of patholog...
- Dilemmas in lung cancer stagin...
- Classification of lung cancer:...
- Negative loop electrosurgical ...
- Solid papillary carcinoma of t...
- Advancing personalized cancer ...
共0条评论